Unity Biotechnology, Inc. Share-based Payment Arrangement, Expensed and Capitalized, Amount
Unity Biotechnology, Inc. reported Share-based Payment Arrangement, Expensed and Capitalized, Amount of $200.00 thousand for the 1-month period ending 2020-03-31, per its 10-Q filed 2022-11-08.
Discontinued › Notes › Share-Based Payment Arrangement
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 · last filed 2022-11-08
- 2020-03-31: Share-based Payment Arrangement, Expensed and Capitalized, Amount 1 month $200.00K.
| Period end | Share-based Payment Arrangement, Expensed and Capitalized, Amount 1 month |
|---|---|
| 2020-03-31 | $200.00K 10-Q · filed 2022-11-08 |